GoodRx Holdings Inc (GDRX)
7.19
+0.11
(+1.55%)
USD |
NASDAQ |
Apr 26, 16:00
7.08
-0.11
(-1.53%)
After-Hours: 20:00
GoodRx Holdings Cash from Investing (TTM): -55.77M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -55.77M |
| September 30, 2023 | -41.61M |
| June 30, 2023 | -41.74M |
| March 31, 2023 | -190.38M |
| December 31, 2022 | -210.50M |
| September 30, 2022 | -221.04M |
| June 30, 2022 | -234.33M |
| Date | Value |
|---|---|
| March 31, 2022 | -203.44M |
| December 31, 2021 | -178.73M |
| September 30, 2021 | -179.28M |
| June 30, 2021 | -225.71M |
| March 31, 2021 | -97.90M |
| December 31, 2020 | -91.62M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-234.33M
Minimum
Jun 2022
-41.61M
Maximum
Sep 2023
-151.70M
Average
-179.28M
Median
Sep 2021
Cash from Investing (TTM) Benchmarks
| American Well Corp | -19.17M |
| MultiPlan Corp | -249.79M |
| Privia Health Group Inc | -42.97M |
| Doximity Inc | 94.15M |
| GeneDx Holdings Corp | -43.73M |